H-KRWIIMGLNK-OH

Ref. 3D-PP47054

Informations sur le produit

• Nom: H-KRWIIMGLNK-OH
• Synonymes: NH2-Lys-Arg-Trp-Ile-Ile-Met-Gly-Leu-Asn-Lys-OH

Description

Peptide H-KRWIIMGLNK-OH is a Research Peptide with significant interest within the field academic and medical research. This peptide is available for purchase at Cymit Quimica in multiple sizes and with a specification of your choice. Recent citations using H-KRWIIMGLNK-OH include the following: HLA-B27 Homodimers and Free H Chains S Kollnberger, K Kuroki, K Maenaka, P Bowness - 2012 - researchgate.nethttps://www.researchgate.net/profile/Simon-Kollnberger/publication/224972647_HLA-B27_Homodimers_and_Free_H_Chains_Are_Stronger_Ligands_for_Leukocyte_Ig-like_Receptor_B2_than_Classical_HLA_Class_1/links/02e7e51c2e0ba91376000000/HLA-B27-Homodimers-and-Free-H-Chains-Are-Stronger-Ligands-for-Leukocyte-Ig-like-Receptor-B2-than-Classical-HLA-Class-1.pdf HLA-B27 heavy chain homodimers are expressed in HLA-B27 transgenic rodent models of spondyloarthritis and are ligands for paired Ig-like receptors S Kollnberger , LA Bird, M Roddis - The Journal of , 2004 - journals.aai.orghttps://journals.aai.org/jimmunol/article/173/3/1699/72361 Cell-surface expression and immune receptor recognition of HLA-B27 homodimers S Kollnberger , L Bird, MY Sun, C Retiere - : Official Journal of , 2002 - Wiley Online Libraryhttps://acrjournals.onlinelibrary.wiley.com/doi/abs/10.1002/art.10605 Cutting edge: HLA-B27 can form a novel beta2-microglobulin-free heavy chain homodimer structure RL Allen , CA O'Callaghan, AJ McMichael - The Journal of , 1999 - journals.aai.orghttps://journals.aai.org/jimmunol/article/162/9/5045/32099 Oligoclonal Expansions of CD8 T Cells in Chronic HIV Infection Are Antigen Specific RL Allen , C O'Callaghan, S Rowland-Jones - academia.eduhttps://www.academia.edu/download/51450821/Oligoclonal_Expansions_of_CD8_T_Cells_in20170120-30843-ppe486.pdf Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS PJR Goulder , RE Phillips, RA CoLBERT , S McAdam - Nature medicine, 1997 - nature.comhttps://www.nature.com/articles/nm0297-212 Uniquely conformed peptide-containing beta2-microglobulin-free heavy chains of HLA-B2705 on the cell surface P Malik, P Klimovitsky, LW Deng, JE Boyson - The Journal of , 2002 - journals.aai.orghttps://journals.aai.org/jimmunol/article/169/8/4379/35458 The effects of natural altered peptide ligands on the whole blood cytotoxic T lymphocyte response to human immunodeficiency virus P Klenerman , UC Meier , RE Phillips - European journal of , 1995 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/eji.1830250720 Co-evolution of human immunodeficiency virus and cytotoxic T-lymphocyte responses P Goulder , D Price, M Nowak - Immunological , 1997 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1600-065X.1997.tb01004.x Importance of a conserved TCR J alpha-encoded tyrosine for T cell recognition of an HLA B27/peptide complex P Bowness, RL Allen , DN Barclay - European journal of , 1998 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1002/(SICI)1521-4141(199809)28:09%3C2704::AID-IMMU2704%3E3.0.CO;2-B Phosphorylated peptides can be transported by TAP molecules, presented by class I MHC molecules, and recognized by phosphopeptide-specific CTL MH Andersen, JE Bonfill, A Neisig - The Journal of , 1999 - journals.aai.orghttps://journals.aai.org/jimmunol/article/163/7/3812/105300 Suboptimal stimulation by weak agonist epitope variants does not drive dysfunction of HIV-1-specific cytotoxic T lymphocyte clones MA Grossman , C Hofmann , HL Ng, OO Yang - AIDS, 2019 - journals.lww.comhttps://journals.lww.com/aidsonline/FullText/2019/08010/Suboptimal_stimulation_by_weak_agonist_epitope.3.aspx HIV-1 escape from the HLA-B27 and HLA-B57 restricted CTL response M Hoeksema - 2014 - studenttheses.uu.nlhttps://studenttheses.uu.nl/handle/20.500.12932/18473 HLA-B27 Heavy Chain Homodimers Are M Breban , AJ McMichael, P Bowness - J Immunol, 2004 - academia.eduhttps://www.academia.edu/download/57223922/1699.pdf An improved assembly assay for peptide binding to HLA-B* 2705 and H-2Kk class I MHC molecules L Tan, MH Andersen, T Elliott, JS Haurum - Journal of immunological , 1997 - Elsevierhttps://www.sciencedirect.com/science/article/pii/S0022175997001427 Misfolding of HLA-B27 as a result of its B pocket suggests a novel mechanism for its role in susceptibility to spondyloarthropathies JP Mear, KL Schreiber, C Munz , X Zhu - The Journal of , 1999 - journals.aai.orghttps://journals.aai.org/jimmunol/article/163/12/6665/7225 Oligoclonal Expansions of CD8+ T Cells in Chronic HIV Infection Are Antigen Specific JDK Wilson, GS Ogg , RL Allen , PJR Goulder - The Journal of , 1998 - rupress.orghttps://rupress.org/jem/article-abstract/188/4/785/7734 Dominant clonotypes within HIV-specific T cell responses are programmed death-1high and CD127low and display reduced variant cross-reactivity JA Conrad , RK Ramalingam, RM Smith - The Journal of , 2011 - journals.aai.orghttps://journals.aai.org/jimmunol/article/186/12/6871/103493 HLA-B27 homodimers and free H chains are stronger ligands for leukocyte Ig-like receptor B2 than classical HLA class I J Giles, J Shaw, C Piper, I Wong-Baeza - The Journal of , 2012 - journals.aai.orghttps://journals.aai.org/jimmunol/article/188/12/6184/86041 NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection G Alter, M Altfeld - Journal of internal medicine, 2009 - Wiley Online Libraryhttps://onlinelibrary.wiley.com/doi/abs/10.1111/j.1365-2796.2008.02045.x Phosphorylated Peptides Can Be Transported by CTL Phosphopeptide-Specific - researchgate.nethttps://www.researchgate.net/profile/John-Haurum/publication/296009219_Phosphorylated_peptides_can_be_transported_by_TAP_molecules_presented_by_class_I_MHC_molecules_and_recognized_by_phosphopeptide-specific_CTL_vol_163_pg_3812_1999/links/56fa5f8108ae7c1fda31ae58/Phosphorylated-peptides-can-be-transported-by-TAP-molecules-presented-by-class-I-MHC-molecules-and-recognized-by-phosphopeptide-specific-CTL-vol-163-pg-3812-1999.pdf

• Marque: Biosynth